|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | |
| A61K 38/17 | |||
| C07K 14/71 | |||
| A61K 38/00 | |||
| C07K 14/72 | |||
| C07K 16/18 |
| (11) | Number of the document | 2805967 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14175663.5 |
| Date of filing the European patent application | 2008-02-04 | |
| (97) | Date of publication of the European application | 2014-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 899304 P | 2007-02-02 | US | |
| 927088 P | 2007-05-01 | US | |
| 931880 P | 2007-05-25 | US |
| (72) |
Knopf, John, US
Kumar, Ravindra, US
Seehra, Jasbir, US
|
| (73) |
Acceleron Pharma, Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | Variants derived from ActRIIB and uses therefor |
| Variants derived from ActRIIB and uses therefor |